Novik, VictoriaVictoriaNovikClaudia García BD Oliva2025-08-252025-08-252017-01-0110.4067/s0034-988720170003000152-s2.0-85019845037https://cris-uv-2.scimago.es/handle/123456789/3138WOS:000400323400015Diabetic ketoacidosis with mild hyperglycemia is a major complication of sodium-glucose cotransporter 2 inhibitors. Although its use is not approved for patients with type 1 diabetes mellitus, the drug is often prescribed with the hope of optimizing metabolic control. We report a 20 years old female with hypo-thyroidism and type 1 diabetes consulting for vomiting and abdominal pain. The patient had used canagliflozin during the two previous months. Laboratory showed a blood glucose of 200 mg/dl, a severe metabolic acidosis (pH 7.1) and ketonemia. The patient was successfully treated in the intensive care unit.esacceso abiertoMedicine, General And InternalMedicinearticle